Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2003 1
2005 2
2006 3
2007 3
2008 1
2009 9
2010 5
2011 4
2012 1
2013 6
2014 5
2015 10
2016 7
2017 13
2018 8
2019 11
2020 11
2021 24
2022 15
2023 10
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

136 results

Results by year

Filters applied: . Clear all
Page 1
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.
Höglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, Müller U, Nilsson C, Whitwell JL, Arzberger T, Englund E, Gelpi E, Giese A, Irwin DJ, Meissner WG, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Bordelon Y, Compta Y, Corvol JC, Colosimo C, Dickson DW, Dodel R, Ferguson L, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris HR, Nestor P, Oertel WH, Poewe W, Rabinovici G, Rowe JB, Schellenberg GD, Seppi K, van Eimeren T, Wenning GK, Boxer AL, Golbe LI, Litvan I; Movement Disorder Society-endorsed PSP Study Group. Höglinger GU, et al. Among authors: van eimeren t. Mov Disord. 2017 Jun;32(6):853-864. doi: 10.1002/mds.26987. Epub 2017 May 3. Mov Disord. 2017. PMID: 28467028 Free PMC article.
Effects of Lee Silverman Voice Treatment BIG and conventional physiotherapy on non-motor and motor symptoms in Parkinson's disease: a randomized controlled study comparing three exercise models.
Schaible F, Maier F, Buchwitz TM, Schwartz F, Hoock M, Schönau E, Libuda M, Hordt A, van Eimeren T, Timmermann L, Eggers C. Schaible F, et al. Among authors: van eimeren t. Ther Adv Neurol Disord. 2021 Feb 18;14:1756286420986744. doi: 10.1177/1756286420986744. eCollection 2021. Ther Adv Neurol Disord. 2021. PMID: 33680093 Free PMC article.
Tau-imaging in neurodegeneration.
Bischof GN, Endepols H, van Eimeren T, Drzezga A. Bischof GN, et al. Among authors: van eimeren t. Methods. 2017 Nov 1;130:114-123. doi: 10.1016/j.ymeth.2017.08.003. Epub 2017 Aug 5. Methods. 2017. PMID: 28790016 Review.
[Dementia with Lewy bodies].
Dodel R, Koschel J, Lorenzl S, Levin J, van Eimeren T, Höglinger G. Dodel R, et al. Among authors: van eimeren t. Fortschr Neurol Psychiatr. 2018 Sep;86(S 01):S43-S47. doi: 10.1055/a-0696-6249. Epub 2018 Sep 21. Fortschr Neurol Psychiatr. 2018. PMID: 30241100 Review. German.
Connectomics and molecular imaging in neurodegeneration.
Bischof GN, Ewers M, Franzmeier N, Grothe MJ, Hoenig M, Kocagoncu E, Neitzel J, Rowe JB, Strafella A, Drzezga A, van Eimeren T; MINC faculty. Bischof GN, et al. Among authors: van eimeren t. Eur J Nucl Med Mol Imaging. 2019 Dec;46(13):2819-2830. doi: 10.1007/s00259-019-04394-5. Epub 2019 Jul 11. Eur J Nucl Med Mol Imaging. 2019. PMID: 31292699 Free PMC article. Review.
Imaging Markers of Progression in Parkinson's Disease.
Strafella AP, Bohnen NI, Pavese N, Vaillancourt DE, van Eimeren T, Politis M, Tessitore A, Ghadery C, Lewis S; IPMDS‐Neuroimaging Study Group. Strafella AP, et al. Among authors: van eimeren t. Mov Disord Clin Pract. 2018 Oct 9;5(6):586-596. doi: 10.1002/mdc3.12673. eCollection 2018 Nov-Dec. Mov Disord Clin Pract. 2018. PMID: 30637278 Free PMC article. Review.
α-Synuclein in Parkinson's disease: causal or bystander?
Riederer P, Berg D, Casadei N, Cheng F, Classen J, Dresel C, Jost W, Krüger R, Müller T, Reichmann H, Rieß O, Storch A, Strobel S, van Eimeren T, Völker HU, Winkler J, Winklhofer KF, Wüllner U, Zunke F, Monoranu CM. Riederer P, et al. Among authors: van eimeren t. J Neural Transm (Vienna). 2019 Jul;126(7):815-840. doi: 10.1007/s00702-019-02025-9. Epub 2019 Jun 25. J Neural Transm (Vienna). 2019. PMID: 31240402 Review.
Biomarkers of Parkinson's disease: 20 years later.
Yilmaz R, Hopfner F, van Eimeren T, Berg D. Yilmaz R, et al. Among authors: van eimeren t. J Neural Transm (Vienna). 2019 Jul;126(7):803-813. doi: 10.1007/s00702-019-02001-3. Epub 2019 Apr 4. J Neural Transm (Vienna). 2019. PMID: 30949837 Review.
Molecular Imaging in Parkinsonian Disorders-What's New and Hot?
Prange S, Theis H, Banwinkler M, van Eimeren T. Prange S, et al. Among authors: van eimeren t. Brain Sci. 2022 Aug 27;12(9):1146. doi: 10.3390/brainsci12091146. Brain Sci. 2022. PMID: 36138882 Free PMC article. Review.
136 results